Raipur: Doctors at state-owned Dr Bhimrao Ambedkar Memorial Hospital, affiliated with Pandit Jawaharlal Nehru Medical College ...

This case is unique because it documents a rare occurrence of a Type IV stent fracture following percutaneous coronary ...

InspireMD, Inc. (the “Company”) (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug Administration (FDA) has ...

Left main coronary artery (LMCA) disease can lead to what's known as a "widowmaker" heart attack, so-called because of the ...

The innovative product is called the Resorbable Fibrillated Scaffold (RFS). In a clinical study, doctors implanted this ...

With a carotid stent, dilation balloon, and integrated embolic protection (IEP) filter for added safety, the system also allows for three steps in one, minimizing manipulation of balloons and stents ...

InspireMD, Inc. (the "Company") (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S.

STENTiT implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in the VITAL-IT 1 study evaluating the ...

One such innovation is the Bioresorbable Scaffold (BRS)-a temporary stent designed to restore blood flow and then dissolve, leaving the artery free of any permanent implant. “Metal stents saved lives, ...

The CGuard Prime carotid stent. [Image from InspireMD] InspireMD announced that the FDA granted premarket approval (PMA) for its CGuard Prime carotid stent system. The CGuard embo ...

Diabetes mellitus is highly prevalent in patients with coronary atherosclerosis. As a result of several factors, including a ...

SNS Insider Unveils Strategic Insights into the U.S. Coronary Stent Market's Acceleration—Valued at USD 4.42 Billion in 2023—As the Nation Leads Global Adoption of Next-Gen Cardiovascular Technologies ...